Want to see ALGS full AI Analyst Report?
Aligos Therapeutics (ALGS) Ownership Overview
46.67%
Insiders
4.22% Mutual Funds
31.17% Other Institutional Investors
3.36% ETFs
14.58% Public Companies and
Individual Investors
The ownership structure of Aligos Therapeutics (ALGS) stock is a mix of institutional, retail, and individual investors. Approximately 38.75% of the company’s stock is owned by Institutional Investors, 46.67% is owned by Insiders, and 14.58% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,120,633 | Insider | 38.95% | 11,748,307 | |
| 394,064 | Insider | 7.24% | 2,183,115 | |
| 183,083 | Insider | 3.36% | 1,014,280 | |
| 177,362 | Institution | 3.26% | 982,585 | |
| 175,543 | Institution | 3.22% | 972,508 | |
| 173,918 | Institution | 3.19% | 963,506 | |
| 83,055 | Institution | 1.53% | 460,125 | |
| 42,352 | Institution | 0.78% | 234,630 | |
| 15,564 | Institution | 0.29% | 86,225 | |
| 9,478 | Institution | 0.17% | 52,508 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 173,918 | Institution | 3.19% | 963,506 | |
| 42,352 | Institution | 0.78% | 234,630 | |
| 4,344 | Institution | 0.08% | 24,066 | |
| 3,347 | Institution | 0.06% | 18,542 | |
| 3,248 | Institution | 0.06% | 17,994 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 128,770 | Institution | 2.37% | 754,592 | |
| 46,773 | Institution | 0.86% | 274,090 | |
| 15,564 | Institution | 0.29% | 86,225 | |
| 8,329 | Institution | 0.15% | 48,058 | |
| 2,810 | Institution | 0.05% | 15,455 | |
| 1,855 | Institution | 0.03% | 10,203 | |
| 1,427 | Institution | 0.03% | 7,849 | |
| 1,149 | Institution | 0.02% | 6,320 | |
| 125 | Institution | <0.01% | 114 | |
| 83 | Institution | <0.01% | 467 |
FAQ
Who Owns Aligos Therapeutics (ALGS)?
According to the latest TipRanks data, approximately 31.17% of the company's stock is held by institutional investors, 46.67% is held by insiders, and 14.58% is held by retail investors.
What percentage of Aligos Therapeutics (ALGS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.17% of Aligos Therapeutics (ALGS) stock is held by institutional investors.
What percentage of Aligos Therapeutics (ALGS) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.58% of Aligos Therapeutics (ALGS) stock is held by retail investors.
Who owns the most shares of Aligos Therapeutics (ALGS)?
LAWRENCE BLATT owns the most shares of Aligos Therapeutics (ALGS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.